|
Market Closed -
Nasdaq
16:00:00 2026-08-20 EDT
|
5-day change | 1st Jan Change | ||
| 6.250 USD | -7.82% |
|
-24.52% | -55.95% |
| 08-12 | RTW Biotech's Avere to go public in US in reverse merger with NextCure | AN |
| 08-12 | RTW Biotech to Inject $6 Million in Avere Therapeutics Ahead of Reverse Merger | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NEXTCURE, INC. | Bio Therapeutic Drugs | -7.82% | -24.52% | -55.95% | +21.83% | -92.57% | 28.61M |  |  | |
- Stock Market
- Stocks
- NXTC Stock
- Charts NextCure, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
